Abstract
Among 200 patients developing hospital-acquired pneumonia (HAP) outside
the intensive care unit, 61% were treated empirically without
broad-spectrum Gram-negative coverage, with clinical cure in 69.7%.
Lower disease severity markers (systemic inflammatory response syndrome,
hypoxia, tachypnoea, neutrophilia) and the absence of diabetes mellitus
and prior doxycycline treatment (but not the time to HAP onset)
identified patients not requiring broad-spectrum Gram-negative coverage.
| Original language | English |
|---|---|
| Article number | ciaa391 |
| Number of pages | 4 |
| Journal | Clinical Infectious Diseases |
| Volume | Advance Article |
| Early online date | 8 Apr 2020 |
| DOIs | |
| Publication status | E-pub ahead of print - 8 Apr 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Hospital-acquired pneumonia
- Gram-negative bacteria
- Doxycycline
- Gentamicin
- Antimicrobial stewardship
Fingerprint
Dive into the research topics of 'A sub-group of patients with hospital-acquired pneumonia do not require broad-spectrum Gram-negative antimicrobial coverage'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver